Susan Kilsby joins Shire's board
This article was originally published in Scrip
Shire has appointed Susan Kilsby to its board of directors on the company's audit, compliance & risk committee, effective 1 September, while current board members, Bill Burns and David Stout will join the nomination committee and remuneration committee respectively with immediate effect. Ms Kilby is currently a non-executive director of skincare company, L'Occitane, and most recently served as chairman of Credit Suisse's EMEA M&A team.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.